4//SEC Filing
Paull Robert Bradley 4
Accession 0001415889-22-006750
CIK 0001479419other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:45 PM ET
Size
5.3 KB
Accession
0001415889-22-006750
Insider Transaction Report
Form 4
Paull Robert Bradley
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2022-06-16+40,000→ 40,000 totalExercise: $0.36Exp: 2032-06-15→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 16, 2022 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 16, 2023 or (ii) the date of the first annual meeting following June 16, 2022.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001711254
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:45 PM ET
- Size
- 5.3 KB